These results suggested that the ERK signaling pathway mediated NaASO2-induced liver lipid metabolism disorders by regulating PPAR-related genes (Figures 2(e), 2(f), and 2(g)). The gene discussed is PPARA; the disease is Disorder of lipid metabolism.